Dissociated single cells of hiPSC lines (201B7, 253G1, 409B2, 454E2, HiPS-RIKEN-1A, HiPS-RIKEN-2A, HiPS-RIKEN-12A, DYR0100, HYR0103, and mc-iPS) were subcutaneously transplanted into NOG mice at 3 × 104 cells with Matrigel and 1 × 106 mitomycin C-treated NHDF in the presence of 10 μM Y-27632. Tumor size was observed for 16 weeks. Six mice were used in each group.</p
<p><b>A</b>) NSG mice were subcutaneously injected in the right flank with 2x10<sup>7</sup> MCV-posi...
<p>Viable tumor cells were harvested from PKF118–310- and DMSO-treated mice and 10,000 viable tumor ...
<p>A) Spherical subcutaneous mass (arrow) in Rag-2<sup>−/−</sup> γ-chain<sup>−/−</sup> mice 36 days ...
Dissociated single cells of hiPSC lines (201B7, 253G1, 409B2, 454E2, HiPS-RIKEN-1A, HiPS-RIKEN-2A, H...
201B7 cells were subcutaneously injected into NOG mice at the indicated doses (0, 1 × 102, 1 × 103, ...
<p>Log<sub>10</sub>TPD<sub>50</sub> value for hiPSC 201B7 determined by subcutaneously transplanting...
<p>The mice received a subcutaneous injection of 0.06 (▲), 0.6 (○), 6 (●), or 60 (∆) µg of PEG-IFN-α...
<p>Both HCCC-9810 and hUC-MSC or HCCC-9810 and HUVEC cells were mixed and subcutaneously inoculated ...
<p>(A) Growth curves of tumors arising from 1 X 10<sup>6</sup> M6 cells implanted into the #2 mammar...
<p>A, Tumor incidence from 3 experiments. Equal numbers of sex matched SCID mice were injected s.c. ...
<p>Female Balb/c nu/nu mice, 8 weeks of age, were being injected subcutaneously in both flanks with ...
<p>HT-1080 cells transfected with the corresponding plasmid construct were injected into the foot pa...
<p>A) shCD5EμTg mice (n = 16) and non-transgenic littermates (n = 15) were injected s.c. with 5×10<s...
<p>C57BL/6 mice were injected s.c. in one flank with 640,000 wild type Panc02 cells. At 11, 18, and ...
<p>(A) 1×10<sup>6</sup> ES cells (MPI-II) or <i>in vitro</i> differentiated cells (day 14 of differe...
<p><b>A</b>) NSG mice were subcutaneously injected in the right flank with 2x10<sup>7</sup> MCV-posi...
<p>Viable tumor cells were harvested from PKF118–310- and DMSO-treated mice and 10,000 viable tumor ...
<p>A) Spherical subcutaneous mass (arrow) in Rag-2<sup>−/−</sup> γ-chain<sup>−/−</sup> mice 36 days ...
Dissociated single cells of hiPSC lines (201B7, 253G1, 409B2, 454E2, HiPS-RIKEN-1A, HiPS-RIKEN-2A, H...
201B7 cells were subcutaneously injected into NOG mice at the indicated doses (0, 1 × 102, 1 × 103, ...
<p>Log<sub>10</sub>TPD<sub>50</sub> value for hiPSC 201B7 determined by subcutaneously transplanting...
<p>The mice received a subcutaneous injection of 0.06 (▲), 0.6 (○), 6 (●), or 60 (∆) µg of PEG-IFN-α...
<p>Both HCCC-9810 and hUC-MSC or HCCC-9810 and HUVEC cells were mixed and subcutaneously inoculated ...
<p>(A) Growth curves of tumors arising from 1 X 10<sup>6</sup> M6 cells implanted into the #2 mammar...
<p>A, Tumor incidence from 3 experiments. Equal numbers of sex matched SCID mice were injected s.c. ...
<p>Female Balb/c nu/nu mice, 8 weeks of age, were being injected subcutaneously in both flanks with ...
<p>HT-1080 cells transfected with the corresponding plasmid construct were injected into the foot pa...
<p>A) shCD5EμTg mice (n = 16) and non-transgenic littermates (n = 15) were injected s.c. with 5×10<s...
<p>C57BL/6 mice were injected s.c. in one flank with 640,000 wild type Panc02 cells. At 11, 18, and ...
<p>(A) 1×10<sup>6</sup> ES cells (MPI-II) or <i>in vitro</i> differentiated cells (day 14 of differe...
<p><b>A</b>) NSG mice were subcutaneously injected in the right flank with 2x10<sup>7</sup> MCV-posi...
<p>Viable tumor cells were harvested from PKF118–310- and DMSO-treated mice and 10,000 viable tumor ...
<p>A) Spherical subcutaneous mass (arrow) in Rag-2<sup>−/−</sup> γ-chain<sup>−/−</sup> mice 36 days ...